In 2023, the total pharmaceutical market in Japan stood at 17.8% in terms of the percentage of generics in value. Forecasted data from 2024 to 2027 show a steady increase, with values reaching 19.7% by 2027. This indicates a consistent rise in the adoption of generics within the pharmaceutical market.
The year-on-year variation from 2023 to 2024 shows an increase of around 2.8%. Looking over the last two years, the same trend continues. The Compound Annual Growth Rate (CAGR) over the five-year period from 2023 to 2027 averages at around 2.7%, highlighting the gradual yet steady shift towards generics.
Future trends to watch for include increased government policies promoting generics, potential cost-containment measures by healthcare providers, and any changes in consumer preferences or perceptions towards generic medications. The impact of technological advancements in drug development and manufacturing could also play a significant role in shaping the market dynamics over the coming years.
